Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Mayer

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Molecular determinants of treatment response in human germ cell tumorsFrank Mayer, Hans Stoop, George L Scheffer, et al.
European Urology|June 28, 2011
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumorsKarin Oechsle, Christian Kollmannsberger, Friedemann Honecker, et al.
Sports Medicine International Open|March 22, 2022
Feasability of An Eccentric Isokinetic Protocol to Induce Trunk Muscle Damage: A Pilot StudyTilman Engel, Anne Schraplau, Monique Wochatz, et al.
Drugs|April 20, 2006
Advances in the treatment of testicular cancerHans-Georg Kopp, Markus Kuczyk, Johannes Classen, et al.
Frontiers in Cellular Neuroscience|September 26, 2019
Poly (ADP-Ribose) Polymerase-1 (PARP1) Deficiency and Pharmacological Inhibition by Pirenzepine Protects From Cisplatin-Induced Ototoxicity Without Affecting Antitumor EfficacyAnke Tropitzsch, Marcus Müller, François Paquet-Durand, et al.
Spine|March 18, 2021
Which Functional Outcomes Can be Measured in Low Back Pain Trials and Therapies?: A Prospective 2-Year Factor-, Cluster-, and Reliability-Multicenter Analysis on 42 Variables in 1049 IndividualsDaniel Niederer, Tilman Engel, Ann-Christin Pfeifer, et al.
Therapeutic Advances in Neurological Disorders|August 2, 2024
No immediate change in systemic cytokines following an eccentric muscle training session in people with multiple sclerosisYasmin Alt, Monique Wochatz, Anne Schraplau, et al.
International Journal of Oncology|July 6, 2006
Cell-cycle progression and response of germ cell tumors to cisplatin in vitroSandra Mueller, Marcus Schittenhelm, Friedemann Honecker, et al.
British Journal of Sports Medicine|May 12, 2012
Medical results of preparticipation examination in adolescent athletesFrank Mayer, Klaus Bonaventura, Michael Cassel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 25, 2011
Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patientsRainer Souchon, Michael Hartmann, Susanne Krege, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Molecular determinants of treatment response in human germ cell tumorsFrank Mayer, Hans Stoop, George L Scheffer, et al.
European Urology|June 28, 2011
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumorsKarin Oechsle, Christian Kollmannsberger, Friedemann Honecker, et al.
Sports Medicine International Open|March 22, 2022
Feasability of An Eccentric Isokinetic Protocol to Induce Trunk Muscle Damage: A Pilot StudyTilman Engel, Anne Schraplau, Monique Wochatz, et al.
Drugs|April 20, 2006
Advances in the treatment of testicular cancerHans-Georg Kopp, Markus Kuczyk, Johannes Classen, et al.
Frontiers in Cellular Neuroscience|September 26, 2019
Poly (ADP-Ribose) Polymerase-1 (PARP1) Deficiency and Pharmacological Inhibition by Pirenzepine Protects From Cisplatin-Induced Ototoxicity Without Affecting Antitumor EfficacyAnke Tropitzsch, Marcus Müller, François Paquet-Durand, et al.
Spine|March 18, 2021
Which Functional Outcomes Can be Measured in Low Back Pain Trials and Therapies?: A Prospective 2-Year Factor-, Cluster-, and Reliability-Multicenter Analysis on 42 Variables in 1049 IndividualsDaniel Niederer, Tilman Engel, Ann-Christin Pfeifer, et al.
Therapeutic Advances in Neurological Disorders|August 2, 2024
No immediate change in systemic cytokines following an eccentric muscle training session in people with multiple sclerosisYasmin Alt, Monique Wochatz, Anne Schraplau, et al.
International Journal of Oncology|July 6, 2006
Cell-cycle progression and response of germ cell tumors to cisplatin in vitroSandra Mueller, Marcus Schittenhelm, Friedemann Honecker, et al.
British Journal of Sports Medicine|May 12, 2012
Medical results of preparticipation examination in adolescent athletesFrank Mayer, Klaus Bonaventura, Michael Cassel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 25, 2011
Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patientsRainer Souchon, Michael Hartmann, Susanne Krege, et al.
Pageof 18